Metabolic dysfunction-associated steatotic liver disease increases the risk of primary open-angle glaucoma.

Ophthalmol Glaucoma

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China; NHC Key Laboratory of Myopia and Related Eye Diseases; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, 200031, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, China; State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, 200032, China. Electronic address:

Published: January 2025

Purpose: Liver disease is associated with a range of extrahepatic complications, which have recently been expanded to include ophthalmic conditions. However, evidence is lacking regarding its impact on primary open-angle glaucoma (POAG). This study aimed to investigate whether major liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), alcoholic liver disease (ALD), viral hepatitis, and liver fibrosis and cirrhosis, were associated with POAG.

Design: A prospective study based on the UK Biobank cohort with a two-sample Mendelian randomization (MR) analysis for inferring causality.

Participants: A total of 332,345 UK Biobank participants free of glaucoma recruited between 2006 and 2010.

Methods: The exposure of interest was severe liver diseases defined as hospital admission, including MASLD, ALD, viral hepatitis, and liver fibrosis and cirrhosis. Cox proportional hazards models were used with each liver disease treated as a time-varying exposure. The MR analysis was further conducted based on the genome-wide association studies of a histologically characterized cohort for MASLD (n = 19,264) and Internation Glaucoma Genetics Consortium cohort for POAG (n = 216,257).

Main Outcome Measures: Risk of POAG estimated by hazard ratio (HR) and 95% confidence interval (CI) in observation analysis, and odds ratio (OR) and 95% CI in MR analysis.

Results: Severe MASLD was associated with a 45% increased risk of POAG (HR 1.45; 95% CI 1.12-1.87; P = 0.005), whereas no association was identified between ALD (P = 0.953), viral hepatitis (P = 0.519), or liver fibrosis and cirrhosis (P = 0.794) and incident POAG. Subgroup analysis showed the risk of POAG in relation to MASLD was higher in individuals having more physical activity (HR 1.53; 95% CI 1.04-2.25 vs. HR 1.39; 95% CI 0.99-1.95, P for interaction = 0.033). MR analysis provided evidence that MASLD was causally associated with greater risk of POAG (inverse-variance weighted model: OR 1.035; 95% CI 1.010-1.061; P = 0.005).

Conclusions: Severe MASLD was longitudinally associated with an increased risk of incident POAG, with MR analyses suggesting a potential causal link. These findings suggest POAG examination should be considered in the holistic management of MASLD, and further underscore the impact of the liver on eye health.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ogla.2024.12.007DOI Listing

Publication Analysis

Top Keywords

liver disease
20
risk poag
16
viral hepatitis
12
liver fibrosis
12
fibrosis cirrhosis
12
liver
11
poag
9
metabolic dysfunction-associated
8
dysfunction-associated steatotic
8
steatotic liver
8

Similar Publications

Background: Intermittent fasting (IF) can be an effective dietary therapy for weight loss and improving cardiometabolic health. However, there is scant evidence regarding the role of IF on indicators of liver function, particularly in adults with metabolic disorders. Therefore, we performed a systematic review and meta-analysis to investigate the effects of IF on liver function in adults with metabolic disorders.

View Article and Find Full Text PDF

Perioperative infections as a prognostic risk factor in hepatocellular carcinoma and cholangiocellular carcinoma: a comparative analysis.

World J Surg Oncol

January 2025

Department for General, Visceral and Pediatric Surgery, Medical Faculty, Heinrich Heine University Düsseldorf, University Hospital Düsseldorf, Düsseldorf, Germany.

Background: Hepatocellular Carcinoma (HCC) and cholangiocellular adenocarcinoma (CCA) are the most common primary liver tumors representing a major global health burden. In early disease stages, tumor resection may provide long-term survival in selected patients. However, morbidity and mortality rates are still relatively high after extended liver surgery with perioperative bacterial infections representing major complications.

View Article and Find Full Text PDF

Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials.

Stem Cell Res Ther

January 2025

School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, 10F., Teaching & Research Building, Shuang-Ho Campus, No. 301, Yuantong Rd., Zhonghe Dist., Taipei, 235, Taiwan.

Chronic liver diseases, including cirrhosis and liver failure, remain formidable challenges due to their complex progression and limited therapeutic options. Mesenchymal stem cell (MSC) therapy has emerged as a game-changing approach, leveraging its potent immunomodulatory, anti-fibrotic, and regenerative capabilities, along with the ability to transdifferentiate into hepatocytes. This review delves into the latest advances in MSC-based treatments for chronic and end-stage liver diseases, as highlighted in current clinical trials.

View Article and Find Full Text PDF

This retrospective study analyzed medical records of 1,392 people living with HIV (PLWH) diagnosed with latent tuberculosis infection (LTBI) at two provincial central hospitals from 2011 to 2022. LTBI was diagnosed in 152 patients (10.9%) patients aged ≥18 years.

View Article and Find Full Text PDF

Characterization of Incident Hepatitis C Virus Infection among People Living with HIV in a HIV Clinic in Korea.

Infect Chemother

December 2024

Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Medical Center, Seoul, Korea.

Background: Coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) can cause more rapid progression to cirrhosis than HCV-monoinfection. In this study, incident HCV case (IHCV)s were investigated in a HIV clinic in Korea.

Materials And Methods: A retrospective HIV cohort was constructed who visited National Medical Center in Korea from 2013 to 2022 and performed ≥ 1 anti-HCV antibody tests (anti-HCV) during the study period.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!